Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have chronic kidney disease (CKD) with kidney function at or above a certain level (an eGFR of 15 ml/min/1.73m² or higher)
- People who are 18 years of age or older
- People whose kidneys are leaking only a moderate amount of protein into their urine (no more than 3.5 grams over a 24-hour period)
- People who have read and signed a consent form agreeing to take part
Who may not be able to join:
- People who have nephrotic syndrome (a condition where the kidneys leak large amounts of protein)
- People who are experiencing an acute (sudden) kidney injury
- People who have previously had kidney replacement treatment, such as dialysis or a kidney transplant
- People whose medications may need to change during the study treatment period
- People who have a history of diabetes or whose recent blood sugar control levels are above a certain threshold (HbA1c greater than 8%)
- People who have a hereditary high cholesterol condition combined with high levels of a specific type of cholesterol (LDL)
- People who have injuries, infections, fractures, or known blood vessel disease in both arms that would make the study's arm-cuff procedure unsafe
- People who have a history of bleeding disorders, widespread bleeding, or a low platelet count
- People who have certain heart conditions, including atrial fibrillation, severe irregular heartbeats, a previous heart attack, or significant heart failure
- People with very high blood pressure that has not been controlled despite taking medication (systolic blood pressure of 200 mmHg or higher)
- People who have respiratory (breathing) failure, cancer, or certain autoimmune diseases
- People who are pregnant or breastfeeding at the time of enrolment or at any point during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guangyan Cai, Chinese PLA General Hospital
Phone: 18911772124
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in eGFR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.